PET Radiochemistry is responsible for the production and development of the radionuclides and radiotracers for clinical and preclinical use at Turku PET Centre.

Our major goals in radiochemistry research are to develop radionuclide production with the aim of producing large quantities of ¹¹C-, ¹⁵O-, ⁶⁸Ga-, ⁶⁴Cu- and ¹⁸F-labelled precursors with high quality, quantity, and specific radioactivity to be used with PET in preclinical and clinical studies according to GMP. We are also continuously developing automated radiosynthetic procedures as well as quality control and radiometabolite analysis for clinical translation of the new methods and tracers.